Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.
Lampertico P, Bogomolov PO, Chulanov V, Stepanova T, Morozov V, Allweiss L, Dandri M, Burhenne J, Blank A, Ciesek S, Elsner C, Dittmer U, An Q, Manuilov D, Da BL, Flaherty JF, Urban S, Wedemeyer H.
Lampertico P, et al. Among authors: an q.
Liver Int. 2025 Feb;45(2):e70008. doi: 10.1111/liv.70008.
Liver Int. 2025.
PMID: 39853842
Free PMC article.
Clinical Trial.